Meeting
2016 Genitourinary Cancers Symposium
Pre-treatment nomogram to predict potency after treatment for localized prostate cancer.
Authors
Joseph Zabell
Cleveland Clinic Foundation, Cleveland, OH
Joseph Zabell , Martin G. Sanda , Mark S. Litwin , Jose Francisco Suarez , Meredith M. Regan , Christopher Saigal , Lorna Kwan , Tianming Gao , Danny Rabah , Eric A. Klein , Michael W. Kattan , Andrew J. Stephenson
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Localized Disease
Citation
J Clin Oncol 34, 2016 (suppl 2S; abstr 32)
DOI
10.1200/jco.2016.34.2_suppl.32
Abstract #
32
Poster Bd #
B14
Abstract Disclosures
Similar Posters
Poster
2012 ASCO Quality Care Symposium
Nomogram predicting treatment-related bowel dysfunction for men with localized prostate cancer treated by radical prostatectomy (RP), external-beam radiotherapy (EBRT), and brachytherapy (PI).
First Author: Joseph Klink
Poster
2012 ASCO Quality Care Symposium
Nomogram predicting treatment-related urinary incontinence for men with localized prostate cancer treated by radical prostatectomy (RP), external-beam radiotherapy (EBRT), or brachytherapy (PI).
First Author: Joseph Klink
Poster
2021 ASCO Annual Meeting
Associations between patient knowledge of others' experiences and treatment choice in men with localized prostate cancer.
First Author: Aaron J. Katz
Poster
2020 Genitourinary Cancers Symposium
18-year prostate cancer-specific mortality after prostatectomy, brachytherapy, external beam radiation therapy, hormonal therapy, or monitoring for localized prostate cancer.
First Author: Annika Herlemann